Journal profile · Medicine-Cardiology and Cardiovascular Medicine

Cardiovascular and Hematological Agents in Medicinal Chemistry

ISSN 1871-5257 · eISSN 1875-6182 · Bentham

Cardiovascular and Hematological Agents in Medicinal Chemistry: subscription journal; median 119 days to acceptance (29 articles, last 24 months); 14 articles in 2025; indexed in Scopus.

Impact factor—No published value
CAS zone—Not in the CAS Journal Ranking
CiteScore quartileQ3Cardiology and Cardiovascular Medicine · rank 207/409
Review time119 daysMedian, submission to acceptance · 29 articles, last 24 months · Crossref
APC—No source gives fee information
Acceptance—No reports yet
Articles per year142025 · OpenAlex count

Scope

Aims, scope and focus

Cardiovascular and Hematological Agents in Medicinal Chemistry is published by Bentham. By OpenAlex counts of its recent articles, its largest topics are Medicinal Plant Research, Blood Coagulation and Thrombosis Mechanisms and Blood Pressure and Hypertension Studies, together about 23.2% of its articles. Its main subfields are Cardiology and Cardiovascular Medicine. (generated from OpenAlex topic counts and CAS ranking data)

Research area (LetPub): Medicine-Cardiology and Cardiovascular Medicine

Main research topics OpenAlex counts of recent articles; shares are approximate

  1. Medicinal Plant ResearchAgricultural and Biological Sciences8.9%
  2. Blood Coagulation and Thrombosis MechanismsMedicine8.2%
  3. Blood Pressure and Hypertension StudiesMedicine6.1%
  4. Natural Antidiabetic Agents StudiesMedicine5.4%
  5. Nitric Oxide and Endothelin EffectsMedicine5.3%
  6. Antiplatelet Therapy and Cardiovascular DiseasesMedicine5.3%
  7. Acute Myocardial Infarction ResearchMedicine4.8%
  8. Venous Thromboembolism Diagnosis and ManagementMedicine4.5%

Rankings & indexing

CAS ranking and database indexing

CAS Journal Ranking

CAS Journal Ranking, upgraded edition (March 2025)Not covered

Not covered by this edition.

CAS Xinrui Journal Ranking (March 2026)Not covered

Not covered by this edition.

CAS Journal Ranking, previous upgraded edition (December 2023)Not covered

Not covered by this edition.

CiteScore quartiles (Scopus, June 2026 release)

SubjectQuartileRankPercentile
Cardiology and Cardiovascular MedicineQ3207/409—
HematologyQ379/151—
PharmacologyQ3213/328—
Clinical BiochemistryQ385/124—

Scopus ranks journals by CiteScore within each subject: the 75th percentile and above is Q1, then a quartile every 25 points. A different system from the CAS zones.LetPub

Database indexing

ScopusLetPub

International journal early-warning lists: not listed in any editionLetPub

Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.

Metrics

Impact metrics and publication volume

Impact

CiteScore 2026-06
2.9LetPub ·
SJR 2026-06
0.32LetPub ·
SNIP 2026-06
0.35LetPub ·
h-index
43OpenAlex ·
i10-index
243OpenAlex ·
2-year mean citedness
1.79OpenAlex ·
Share of gold OA articles
0%LetPub ·

Articles by year OpenAlex count · 595 in total · the current year is incomplete

YearArticlesOpen accessCitations
2026181355
2025140528
2024304587
2023424633
2022314567
2021233533

Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.

Review & acceptance

Review time and acceptance

Review time from article dates manuscript dates registered with Crossref · to

119 daysMedian, submission to acceptance · P25–P75 105 days – 145 days

Acceptance to online
median 190 days (29 articles)
Submission to online
median 299 days
Sample
29 articles with submission and acceptance dates (56 in the window); the latest was accepted on

Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".

Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.

Fees & open access

APC and open-access policy

Subscription journalLetPub

A subscription journal: articles are read by subscription or purchase, and authors usually pay no publication charge.

No source has fee information yet; check the journal's website.

The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.

Profile

Publication details and official links

Publisher
Bentham
ISSN
1871-5257
Electronic ISSN
1875-6182

FAQ

Frequently asked questions about Cardiovascular and Hematological Agents in Medicinal Chemistry

How long does peer review take at Cardiovascular and Hematological Agents in Medicinal Chemistry?

Based on the dates recorded on 29 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 119 days (interquartile range 105–145 days). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.

Which databases index Cardiovascular and Hematological Agents in Medicinal Chemistry?

According to LetPub and DOAJ records, Cardiovascular and Hematological Agents in Medicinal Chemistry is indexed in Scopus.

Is Cardiovascular and Hematological Agents in Medicinal Chemistry open access, and what is the APC?

Cardiovascular and Hematological Agents in Medicinal Chemistry is a subscription journal. Fee information is not available yet; check the journal's website.

Sources and updates

The facts on this page come from LetPub, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .